Most patients report feeling satisfied with smaller portion sizes and experiencing reduced cravings for high-calorie foods
In addition, the limitations of GLP-1R agonist therapy, which may cause gastrointestinal adverse effects and significantly alter the patients physiological state, make it not widely applicable to all patients
All research protocols were reviewed and approved by the Amgen Institutional Animal Care and Use Committee (Thousand Oaks, CA), Toronto Centre for Phenogenomics at Mount Sinai Hospital (Toronto, Canada) and Danish Animal Experimentation Council (Hrsholm, Denmark)
FSA and HSA Eligibility If you have a Flexible Spending Account (FSA) or Health Savings Account (HSA), GLP-1 medications are generally eligible expenses
As research continues, it is becoming more and more apparent that their benefits extend beyond glucose regulation